Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amy Collins

Showing results (31-40 of 39) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 39 results.
The American Journal of Pathology|January 23, 2023
miRNA Expression in Fibroblastic Foci within Idiopathic Pulmonary Fibrosis Lungs Reveals Novel Disease-Relevant PathwaysLaura Sabater, Jean B Gossart, Inmaculada Hernandez, et al.
JAMA Internal Medicine|May 13, 2024
Mail-Order Pharmacy Dispensing of Mifepristone for Medication Abortion After In-Person ScreeningDaniel Grossman, Sarah Raifman, Natalie Morris, et al.
International Journal of Radiation Oncology, Biology, Physics|July 16, 2022
Transitioning to Environmentally Sustainable, Climate-Smart Radiation Oncology CareKatie E Lichter, Justin Anderson, Austin J Sim, et al.
European Heart Journal|December 10, 2013
Cardiologists urged to reduce inappropriate radiation exposureJennifer Taylor, Sidney C Smith, Amy Collins, et al.
Hepatology (Baltimore, Md.)|September 11, 2022
c-Rel-dependent Chk2 signaling regulates the DNA damage response limiting hepatocarcinogenesisJack Leslie, Jill E Hunter, Amy Collins, et al.
Bioscience Reports|May 29, 2024
UCHL1-dependent control of hypoxia-inducible factor transcriptional activity during liver fibrosisAmy Collins, Rebecca Scott, Caroline L Wilson, et al.
Annals of the American Thoracic Society|March 16, 2026
Strategies to Meaningfully Reduce Healthcare Sector Emissions in Pulmonary, Critical Care, and Sleep PracticeJared Radbel, Emily Brigham, Hasan Bayram, et al.
Nature Metabolism|September 25, 2024
Damaging mutations in liver X receptor-α are hepatotoxic and implicate cholesterol sensing in liver healthSam M Lockhart, Milan Muso, Ilona Zvetkova, et al.
Gut|April 28, 2022
CXCR2 inhibition enables NASH-HCC immunotherapyJack Leslie, John B G Mackey, Thomas Jamieson, et al.
Pageof 4

Showing results (31-40 of 39) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
The American Journal of Pathology|January 23, 2023
miRNA Expression in Fibroblastic Foci within Idiopathic Pulmonary Fibrosis Lungs Reveals Novel Disease-Relevant PathwaysLaura Sabater, Jean B Gossart, Inmaculada Hernandez, et al.
JAMA Internal Medicine|May 13, 2024
Mail-Order Pharmacy Dispensing of Mifepristone for Medication Abortion After In-Person ScreeningDaniel Grossman, Sarah Raifman, Natalie Morris, et al.
International Journal of Radiation Oncology, Biology, Physics|July 16, 2022
Transitioning to Environmentally Sustainable, Climate-Smart Radiation Oncology CareKatie E Lichter, Justin Anderson, Austin J Sim, et al.
European Heart Journal|December 10, 2013
Cardiologists urged to reduce inappropriate radiation exposureJennifer Taylor, Sidney C Smith, Amy Collins, et al.
Hepatology (Baltimore, Md.)|September 11, 2022
c-Rel-dependent Chk2 signaling regulates the DNA damage response limiting hepatocarcinogenesisJack Leslie, Jill E Hunter, Amy Collins, et al.
Bioscience Reports|May 29, 2024
UCHL1-dependent control of hypoxia-inducible factor transcriptional activity during liver fibrosisAmy Collins, Rebecca Scott, Caroline L Wilson, et al.
Annals of the American Thoracic Society|March 16, 2026
Strategies to Meaningfully Reduce Healthcare Sector Emissions in Pulmonary, Critical Care, and Sleep PracticeJared Radbel, Emily Brigham, Hasan Bayram, et al.
Nature Metabolism|September 25, 2024
Damaging mutations in liver X receptor-α are hepatotoxic and implicate cholesterol sensing in liver healthSam M Lockhart, Milan Muso, Ilona Zvetkova, et al.
Gut|April 28, 2022
CXCR2 inhibition enables NASH-HCC immunotherapyJack Leslie, John B G Mackey, Thomas Jamieson, et al.
Pageof 4